Pharmacokinetic overview of oral second-generation H1 antihistamines

International Journal of Clinical Pharmacology and Therapeutics

Volumn 36, Issue 5, 1998, Pages 292-300

  Gonzalez M A ^a   Estes, K S ^b  

^a P'Kinetics Inc   (United States)

^b NONE

Author keywords

Astemizole; Cetirizine; Fexofenadine; H1 antagonists; Loratadine; Pharmacokinetics; Terfenadine

Indexed keywords

ANTIHISTAMINIC AGENT; ASTEMIZOLE; CETIRIZINE; FEXOFENADINE; HISTAMINE H1 RECEPTOR ANTAGONIST; LORATADINE; TERFENADINE;

ALLERGIC RHINITIS; ARTICLE; BLOOD BRAIN BARRIER; CHOLINERGIC ACTIVITY; CLINICAL TRIAL; DROWSINESS; DRUG WITHDRAWAL; HEART VENTRICLE TACHYCARDIA; HUMAN; META ANALYSIS; PATIENT COMPLIANCE; QT INTERVAL; TORSADE DES POINTES; XEROSTOMIA;

ASTEMIZOLE; BLOOD-BRAIN BARRIER; CETIRIZINE; HISTAMINE H1 ANTAGONISTS; HUMANS; LORATADINE; STRUCTURE-ACTIVITY RELATIONSHIP; TERFENADINE; THERAPEUTIC EQUIVALENCY; TORSADES DE POINTES;

EID: 2642619438     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Allen J 1996 Detail Document #120819, New Drug: Fexofenadine (Allegra). Pharmacist Letter 12: 8
2. 3 receptors. Nature 327: 117
3. Babe KS, Serafin WE 1996 Histamine, bradykinin, and their antagonists. In: Hardman JG, Limbird LE et al (eds) Goodman and Gilman's Pharmacological Basis of Therapeutics. McGraw Hill, New York, pp 581-600
4. Bedard PM, Del Carpio J, Drouin MA et al 1992 Onset of action of loratadine and placebo and other efficacy variables in patients with seasonal allergic rhinitis. Clin Ther 14: 268-275
5. Benton RE, Honig PK, Zamani K et al 1996 Grapefruit juice alters terfenadine pharmacokinetics, resulting in prolongation of repolarization on the electrocardiogram. Clin Pharmacol Ther 59: 383-388
6. Bernstein JA 1993 Antihistamines. In: Patterson R (ed) Allergic Diseases Diagnosis and Management (4th edition). Lippincott, Philadelphia, pp 73-91
7. 2 receptors. Nature 236: 385
8. Bovet D 1950 Introduction to antihistamine agents and antergan derivatives. Ann NY Acad Sci 50: 1089-1126
9. Brannan MD, Reidenberg P, Radwanski E et al 1995 Loratadine administered concomitantly with erythromycin: Pharmacokinetic and electrocardiographic evaluations. Clin Pharmacol Ther 58: 269-278
10. Callier J, Engelen RF, Iannielle I et al 1981 Astemizole (R43512) in the treatment of hay fever: An international double-blind study comparing a weekly treatment (10 and 25 mg) with a placebo. Curr Ther Res 29: 24-35
11. 1-antihistamines. Clin Pharmacokinet 28: 419-432
12. 1-receptor antagonist cetirizine in very young children. Clin Pharmacol Ther 53: 431-435
13. Eller MG, Walker BJ, Westmark PA et al 1992 Pharmacokinetics of terfenadine in healthy elderly subjects. J Clin Pharmacol 32: 267-271
14. FDA Talk Paper 1998 Important new safety information about Hismanal. Food and Drug Administration, Rockville, MD
15. Haria M, Fitton A, Peters DH 1994 Loratadine: a reappraisal of its pharmacological properties and therapeutic use in allergic disorders. Drugs 48: 617-637
16. Honig PK, Woosley RL, Zamani K et al 1992 Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin. Clin Pharmacol Ther 52: 231-238
17. Honig PK, Wortham DC, Lazarev A et al 1996 Grapefruit juice alters the systemic bioavailability and cardiac repolarization of terfenadine in poor metabolizers of terfenadine. J Clin Pharmacol 36: 345-351
18. Honig PK, Wortham DC, Zamani K et al 1993 Terfenadine-ketoconazole interaction. Pharmacokinetic and electrocardiographic consequences. JAMA 269 1513-1518
19. Horsmans Y, Desager JP, Hulhoven K et al 1993 Single dose pharmacokinetics of cetirizine in patients with chronic liver disease. J Clin Pharmacol 33: 929-932
20. 1-receptor antagonist: effect in allergic rhinoconjunctivitis on antigen-and histamine-induced skin wheal responses and relationship to serum levels. Br J Clin Pharmacol 18: 1-8
21. Kamei C, Mio M, Izushi K et al 1991 Antiallergic effects of major metabolite of astemizole in rats and guinea pigs. Arzneimittelforschung 41: 932-936
22. Kamisako T, Adachi Y, Nakagawa H et al 1995 Torsades de pointes associated with terfenadine in a case of liver cirrhosis and hepatocellular carcinoma. Int Med 34: 92-95
23. Ling KH, Leeson GA, Burmaster SD et al 1995 Metabolism of terfenadine associated with CYP3A(4) activity in human hepatic microsomes. Drug Metab Dispos 23: 631-636
24. Lucas BD, Purdy CY, Scarim SK et al 1995 Terfenadine pharmacokinetics in breast milk in lactating women. Clin Pharmacol Ther 57: 398-402
25. MacConnell TJ, Stanners AJ 1991 Torsades de pointes complicating treatment with terfenadine. Br Med J 302: 1469
26. Monahan BP, Ferguson CL, Killeavy ES et al 1990 Torsades de pointes occurring in association with terfenadine use. JAMA 264: 2788-2790
27. Moller C, Andlin-Sobocki P, Blychert LO 1992 Pharmacokinetics of astemizole in children. Rhinology 13 (Suppl): 21-25
28. Nightingale CH 1996 Treating allergic rhinitis with second-generation antihistamines. Pharmacotherapy 16: 905-914
29. Nomeir AA, Mojaverian P, Kosoglou T et al 1996 Influence of food on the oral bioavailability of loratadine and pseudoephedrine from extended-release tablets in healthy volunteers. J Clin Pharmacol 36: 923-930
30. Oei HD 1988 Double-blind comparison of loratidine (SCH 29851), astemizole, and placebo in hay fever with special regard to onset of action. Ann Allergy 61: 436-439
31. Radwanski E, Hilbert J, Symchowicz S et al 1987 Loratadine: multiple dose pharmacokinetics. J Clin Pharmacol 27: 530-533
32. 1 receptor antagonist treatment of chronic rhinitis. J Allergy Clin Immunol 81: 975
33. 1 receptor antagonists: Clinical pharmacology and therapeutics. J Allergy Clin Immunol 84: 845
34. 1 receptor antagonists: Clinical pharmacology. Clin Exp Allergy 20 (Suppl 2): 19-24
35. 1 receptor antagonist treatment. J Allergy Clin Immunol 86: 995-999
36. Simons FER, Bergman JN, Watson WTA, Simons KJ 1996 The clinical pharmacology of fexofenadine in children. J Allergy Clin Immunol 98: 1062-1064
37. Sorkin EM, Heel RC 1985 Terfenadine: a review of its pharmacodynamic properties and therapeutic efficacy. Drugs 29: 34-56
38. Spencer C, Faulds D, Peters DH 1993 Cetirizine. A reappraisal of its pharmacological properties and therapeutic use in selected allergic disorders. Drugs 46: 1055-1080
39. Stoltz M, Arumugham T, Lippen C et al 1997 Effect of food on the bioavailability of fexofenadine hydrochloride (MDL 16455A). Biopharm Drug Dispos 18: 645-648
40. Sugiyama A, Aye NN, Katahira S et al 1997 Effects of nonsedating antihistamine, astemizole, on the in situ canine heart assessed by cardiohemodynamic and monophasic action potential monitoring. Toxicol Appl Pharmacol 143: 89-95
41. Von Moltke LL, Greenblatt DJ, Xiang Duan S et al 1996 Inhibition of terfenadine metabolism in vitro by azole antifungal agents and by selective serotonin reuptake inhibitor antidepressants: Relation to pharmacokinetic interactions in vivo. J Clin Psychopharm 16: 112
42. Wood SG, John BA, Chasseaud LF et al 1987 The metabolism and pharmacokinetics of 14C-cetirizine in humans. Ann Allergy 59: 31-4
43. Yumihe N, Huis K, Chen KJ et al 1994 Identification of human liver cytochrome P450 involved in the metabolism of loratadine. J Allergy Clin Immunol 234 (Suppl): A17